bf/NASDAQ:VRTX_icon.jpeg

NASDAQ:VRTX

Vertex Pharmaceuticals Incorporated

  • Stock

USD

Last Close

416.25

06/11 21:01

Market Cap

126.86B

Beta: 0.49

Volume Today

1.45M

Avg: 1.12M

PE Ratio

31.95

PFCF: 26.33

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24
revenue
580.41M
-
1.03B
77.86%
1.70B
64.89%
2.49B
46.20%
3.05B
22.46%
4.16B
36.59%
6.21B
49.07%
7.57B
22.06%
8.93B
17.91%
9.84B
10.17%
11.02B
12.00%
cost of revenue
60.99M
-
125.54M
105.85%
210.46M
67.64%
275.12M
30.72%
409.54M
48.86%
547.76M
33.75%
736.30M
34.42%
904.20M
22.80%
1.08B
19.48%
1.26B
16.84%
1.53B
21.26%
gross profit
519.43M
-
906.79M
74.58%
1.49B
64.50%
2.21B
48.39%
2.64B
19.18%
3.62B
37.04%
5.47B
51.29%
6.67B
21.96%
7.85B
17.69%
8.58B
9.25%
9.49B
10.64%
selling and marketing expenses
general and administrative expenses
selling general and administrative expenses
305.41M
-
377.08M
23.47%
432.83M
14.78%
496.08M
14.61%
557.62M
12.40%
658.50M
18.09%
770.46M
17.00%
840.10M
9.04%
944.70M
12.45%
1.14B
20.31%
1.46B
28.83%
research and development expenses
855.51M
-
996.17M
16.44%
1.05B
5.17%
1.32B
26.43%
1.42B
6.93%
1.75B
23.87%
1.83B
4.27%
3.05B
66.77%
2.54B
16.74%
3.69B
45.26%
3.63B
1.62%
other expenses
30.40M
-
-6.71M
122.08%
4.13M
161.52%
-81.38M
2,070.51%
-790K
99.03%
192.18M
24,426.20%
296.42M
54.24%
4.90M
98.35%
-164.80M
3,463.27%
-22.80M
86.17%
4.63B
20,397.81%
cost and expenses
1.22B
-
1.50B
22.66%
1.69B
12.82%
2.10B
23.94%
2.38B
13.73%
2.96B
24.21%
3.34B
12.68%
4.80B
43.73%
4.57B
4.80%
6.09B
33.37%
11.25B
84.81%
operating expenses
1.16B
-
1.37B
18.29%
1.48B
7.81%
1.82B
22.98%
1.97B
8.42%
2.41B
22.24%
2.60B
7.75%
3.89B
49.66%
3.48B
10.44%
4.83B
38.50%
9.72B
101.44%
interest expense
72.86M
-
84.21M
15.57%
81.43M
3.29%
57.55M
29.33%
34.12M
40.71%
58.50M
71.46%
58.15M
0.60%
61.50M
5.76%
54.80M
10.89%
44.10M
19.53%
30.60M
30.61%
ebitda
-611.09M
-
-473.17M
22.57%
15.33M
103.24%
311.45M
1,931.88%
663.18M
112.93%
1.46B
119.83%
3.19B
118.68%
2.79B
12.52%
4.35B
55.81%
3.93B
9.52%
486.30M
87.63%
operating income
-692.41M
-
-468.66M
32.31%
9.94M
102.12%
123.24M
1,140.37%
635.15M
415.36%
1.20B
88.55%
2.86B
138.51%
2.78B
2.60%
4.31B
54.83%
3.75B
12.94%
-232.90M
106.21%
depreciation and amortization
63.26M
-
62.34M
1.44%
61.40M
1.52%
61.40M
0.00%
72.42M
17.95%
260.31M
259.45%
331.76M
27.45%
6.70M
97.98%
37.80M
464.18%
181.30M
379.63%
205.80M
13.51%
total other income expenses net
-20.52M
-
-8.92M
56.55%
2.87M
132.16%
-350.97M
12,337.38%
-29.61M
91.56%
197.35M
766.60%
260.51M
32.00%
-51.70M
119.85%
-75M
45.07%
629.60M
939.47%
481.40M
23.54%
income before tax
-734.88M
-
-559.58M
23.85%
-67.37M
87.96%
-15.69M
76.71%
600.24M
3,925.87%
1.39B
132.39%
3.12B
123.44%
2.73B
12.40%
4.23B
55.01%
4.38B
3.48%
248.50M
94.33%
income tax expense
6.96M
-
30.38M
336.63%
16.66M
45.15%
-107.32M
744.01%
-1.49B
1,285.40%
218.11M
114.67%
405.15M
85.76%
388.30M
4.16%
910.40M
134.46%
760.20M
16.50%
784.10M
3.14%
net income
-738.55M
-
-558.12M
24.43%
-112.05M
79.92%
263.48M
335.14%
2.10B
695.83%
1.18B
43.88%
2.71B
130.42%
2.34B
13.63%
3.32B
41.84%
3.62B
8.96%
-535.60M
114.80%
weighted average shs out
235.31M
-
241.31M
2.55%
244.69M
1.40%
248.86M
1.71%
254.29M
2.18%
256.73M
0.96%
259.84M
1.21%
257.70M
0.82%
256.10M
0.62%
257.70M
0.62%
257.50M
0.08%
weighted average shs out dil
235.31M
-
241.31M
2.55%
244.69M
1.40%
253.22M
3.49%
259.19M
2.35%
260.67M
0.57%
263.40M
1.04%
259.90M
1.33%
259.10M
0.31%
260.50M
0.54%
257.90M
1.00%
eps
-3.14
-
-2.31
26.43%
-0.46
80.09%
1.06
330.43%
8.25
678.30%
4.58
44.48%
10.44
127.95%
9.09
12.93%
12.97
42.68%
14.05
8.33%
-2.08
114.80%
epsdiluted
-3.14
-
-2.31
26.43%
-0.46
80.09%
1.04
326.09%
8.09
677.88%
4.51
44.25%
10.29
128.16%
9.01
12.44%
12.82
42.29%
13.89
8.35%
-2.08
114.97%

All numbers in USD (except ratios and percentages)